ACTON, Mass., June 10, 2025--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology, is excited to announce that the Omnipod ® 5 App for iPhone is ...

As Americans flock to nearby orchards for festive bouts of autumn apple picking, Insulet is celebrating a particularly bountiful stateside Apple harvest itself. The diabetes devicemaker has earned FDA ...

Insulet recently announced that its Omnipod® 5 App for iPhone is now compatible with the Dexcom G7 Continuous Glucose Monitoring System, enhancing its Automated Insulin Delivery capabilities. Over the ...

Insulet, which specializes in tubeless insulin pump technology with its Omnipod brand of products, today announced it has received FDA 510(k) clearance for the Omnipod 5 App for iPhone. This makes ...

Insulet (($PODD)) announced an update on their ongoing clinical study. Insulet Corporation has announced a new clinical study titled ‘Omnipod 5 – ...

Insulet (($PODD)) announced an update on their ongoing clinical study. Insulet Corporation is conducting a clinical study titled ‘Safety and ...

The FDA has handed down a Class I recall label, the agency’s most serious, to a now-corrected software issue that could have resulted in delivering ten times the desired insulin dose from Insulet’s ...

BEDFORD, Mass., June 3 Insulet Corporation(Nasdaq: PODD), a leader in wearable insulin pump technology with itsOmniPod(R) Insulin Management System, today announced an agreement withFerring ...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today presented ...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced ...